As of 2025-09-16, the Intrinsic Value of Rapt Therapeutics Inc (RAPT) is -41.02 USD. This RAPT valuation is based on the model Peter Lynch Fair Value. With the current market price of 17.41 USD, the upside of Rapt Therapeutics Inc is -335.56%.
Based on its market price of 17.41 USD and our intrinsic valuation, Rapt Therapeutics Inc (RAPT) is overvalued by 335.56%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -41.02 - -41.02 | -41.02 | -335.56% |
| P/E | (55.63) - (92.71) | (70.35) | -504.0% |
| DDM - Stable | (44.83) - (135.81) | (90.32) | -618.6% |
| DDM - Multi | (46.21) - (114.82) | (66.56) | -482.2% |
| Market Cap (mil) | 226.04 |
| Beta | 1.73 |
| Outstanding shares (mil) | 12.98 |
| Enterprise Value (mil) | 184.15 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.12% |
| Cost of Debt | 5.00% |
| WACC | 8.40% |